AFLIBERCEPT — all Canadian products
19 DINs
17 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AFLIBERCEPT, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02554178 | AFLIVU | APOTEX INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02554194 | AFLIVU | APOTEX INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02562928 | AHZANTIVE | VALORUM BIOLOGICS LLC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Approved | |
| 02562529 | ENZEEVU | SANDOZ CANADA INCORPORATED | Solution | Intravitreal | AFLIBERCEPT 2 MG | Approved | |
| 02562510 | ENZEEVU | SANDOZ CANADA INCORPORATED | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02563045 | EYDENZELT | CELLTRION INC. | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02563037 | EYDENZELT | CELLTRION INC. | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02415992 | EYLEA | BAYER INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02505355 | EYLEA | BAYER INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02545004 | EYLEA HD | BAYER INC | Solution | Intravitreal | AFLIBERCEPT 8 MG | Marketed | |
| 02554798 | EYLEA HD | BAYER INC | Solution | Intravitreal | AFLIBERCEPT 8 MG | Marketed | |
| 02561891 | OPUVIZ | SAMSUNG BIOEPIS CO., LTD | Solution | Intravitreal | AFLIBERCEPT 2 MG | Approved | |
| 02561883 | OPUVIZ | SAMSUNG BIOEPIS CO., LTD | Solution | Intravitreal | AFLIBERCEPT 2 MG | Approved | |
| 02550628 | PAVBLU | AMGEN CANADA INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Approved | |
| 02550636 | PAVBLU | AMGEN CANADA INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02535858 | YESAFILI | BIOCON BIOLOGICS CANADA INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02558238 | YESAFILI | BIOCON BIOLOGICS CANADA INC | Solution | Intravitreal | AFLIBERCEPT 2 MG | Marketed | |
| 02421089 | ZALTRAP | SANOFI-AVENTIS CANADA INC | Solution | Intravenous | AFLIBERCEPT 200 MG | Cancelled Post Market | |
| 02421070 | ZALTRAP | SANOFI-AVENTIS CANADA INC | Solution | Intravenous | AFLIBERCEPT 100 MG | Cancelled Post Market |
Browse other molecules: